Risk-to-Benefit Ratio of Venous Thromboembolism Prophylaxis for Neurosurgical Procedures at a Quaternary Referral Center
暂无分享,去创建一个
P. Gerszten | N. Agarwal | R. Friedlander | Frank J Walch | Eileen Roach | P. Agarwal | G. Zenonos | Sandra J Stokes | E. Roach
[1] D. Damania,et al. Systematic Review of Safety and Cost‐Effectiveness of Venous Thromboembolism Prophylaxis Strategies in Patients Undergoing Craniotomy for Brain Tumor , 2018, Neurosurgery.
[2] Jodi L. Smith,et al. Risk of deep venous thrombosis in elective neurosurgical procedures: a prospective, Doppler ultrasound-based study in children 12 years of age or younger. , 2017, Journal of neurosurgery. Pediatrics.
[3] K. Bekelis,et al. Risk of Venous Thromboembolism and Operative Duration in Patients Undergoing Neurosurgical Procedures , 2017, Neurosurgery.
[4] E. Aytaç,et al. The Use of Surgical Care Improvement Projects in Prevention of Venous Thromboembolism. , 2016, Advances in experimental medicine and biology.
[5] K. Bilimoria,et al. Evaluation of an institutional project to improve venous thromboembolism prevention. , 2016, Journal of hospital medicine.
[6] K. Bailey,et al. Corrigendum to ‘Direct medical costs attributable to venous thromboembolism among persons hospitalized for major operation: A population-based longitudinal study’: [Surgery 2015;157:423-31] , 2015 .
[7] B. Jahromi,et al. Analysis of Venous Thromboembolism Risk in Patients Undergoing Craniotomy. , 2015, World neurosurgery.
[8] B. Jahromi,et al. Clinical factors associated with venous thromboembolism risk in patients undergoing craniotomy. , 2015, Journal of neurosurgery.
[9] K. Bailey,et al. Direct medical costs attributable to venous thromboembolism among persons hospitalized for major operation: a population-based longitudinal study. , 2015, Surgery.
[10] K. Bailey,et al. Direct Medical Costs Attributable to Venous Thromboembolism among Persons Hospitalized for Major Surgery: A Population-based Longitudinal Study , 2015 .
[11] A. Neugut,et al. Incidence, cost, and mortality associated with hospital-acquired conditions after resection of cranial neoplasms. , 2014, Neurosurgery.
[12] R. Strom,et al. Low-Molecular-Weight Heparin Prophylaxis 24 to 36 Hours After Degenerative Spine Surgery: Risk of Hemorrhage and Venous Thromboembolism , 2013, Spine.
[13] Michael K Gould,et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.
[14] W. Ghali,et al. Venous Thromboembolism Prophylaxis in Patients Undergoing Cranial Neurosurgery: A Systematic Review and Meta-analysis , 2011, Neurosurgery.
[15] M. Marden,et al. Prevalence of clinical venous thromboembolism in the USA: Current trends and future projections , 2011, American journal of hematology.
[16] S. Rathbun. Cardiology patient pages. The Surgeon General's call to action to prevent deep vein thrombosis and pulmonary embolism. , 2009, Circulation.
[17] K. Wood,et al. Thromboembolic Disease in Spinal Surgery: A Systematic Review , 2009, Spine.
[18] Moira C McKinnon,et al. Closing the Quality Gap: A Critical Analysis of Quality Improvement Strategies (Vol. 7: Care Coordination) , 2007 .
[19] Jonathan Dreyer,et al. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. , 2003, The New England journal of medicine.